EXTRAPOLATION OF DACLATASVIR DOSING RECOMMENDATIONS FROM RITONAVIR BOOSTED PROTEASE INHIBITORSTO COBICISTAT PROTEASE INHIBITORS

被引：0
|
作者：
Gandhi, Y. [1 ]
Wang, Q. [1 ]
Li, W. [1 ]
Eley, T. [1 ]
Zheng, M. [1 ]
LaCreta, F. [1 ]
Bertz, R. [1 ]
Garimella, T. [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-044
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [31] Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
    Martinez, Esteban
    Larrousse, Maria
    Llibre, Josep M.
    Gutierrez, Felix
    Saumoy, Maria
    Antela, Antonio
    Knobel, Hernando
    Murillas, Javier
    Berenguer, Juan
    Pich, Judit
    Perez, Ignacio
    Gatell, Jose M.
    AIDS, 2010, 24 (11) : 1697 - 1707
  • [32] Iatrogenic Hypercortisolism Complicating Triamcinolone Acetonide Injections in Patients with HIV on Ritonavir-Boosted Protease Inhibitors
    Fessler, David
    Beach, Jennifer
    Keel, John
    Stead, Wendy
    PAIN PHYSICIAN, 2012, 15 (06) : 489 - 493
  • [33] Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
    Fisher, Martin
    McDonald, Cheryl
    Moyle, Graeme
    Martorell, Claudia
    Ramgopal, Moti
    Laplante, Francois
    Curley, Joanne
    Graham, Hiba
    Tran-Muchowski, Cecilia
    Liu, Yapei
    Rhee, Martin
    Szwarcberg, Javier
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 203 - 203
  • [34] Tipranavir: A Ritonavir-Boosted Protease InhibitorA Viewpoint by Charles Hicks
    Charles Hicks
    Drugs, 2005, 65 : 1678 - 1678
  • [35] Effectiveness of ritonavir-boosted protease inhibitor monotherapy in routine practice
    Fonquernie, L.
    Lefebvre, B.
    Valin, N.
    Morand-Joubert, L.
    Boyd, A.
    Meynard, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 155 - 155
  • [36] Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir
    Martinez, Esteban
    d'Albuquerque, Polyana M.
    Perez, Ignacio
    Pich, Judit
    Gatell, Jose M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (02) : 235 - 241
  • [37] More ADRs with ritonavir than other protease inhibitors
    Reactions Weekly, 2000, 806 (1) : 5 - 5
  • [38] Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy
    Lichterfeld, M
    Wöhrmann, A
    Schmeisser, N
    Fätkenheuer, G
    Salzberger, B
    Wyen, C
    Schmitz, K
    Sauerbruch, T
    Rockstroh, JK
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2003, 8 (02) : 56 - 60
  • [39] Sildenafil Plasma Concentrations in Two HIV Patients with Pulmonary Hypertension Treated with Ritonavir-Boosted Protease Inhibitors
    Chinello, Pierangelo
    Cicalini, Stefania
    Pichini, Simona
    Pacifici, Roberta
    Tempestilli, Massimo
    Petrosillo, Nicola
    CURRENT HIV RESEARCH, 2012, 10 (02) : 162 - 164
  • [40] Is Ritonavir-boosted Protease Inhibitors (PIs/r) monotherapy noninferior to classic combined antiretroviral therapy (cART)?
    Mikula, Tomasz
    Dabrowska, Magdalena
    Wiercinska-Drapalo, Alicja
    HIV & AIDS REVIEW, 2010, 9 (03): : 61 - 64
12345